Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Sequenom Announces Multi-Year Supply Agreement With Illumina

July 11, 2011 By Bio-Medicine.Org

SAN DIEGO, July 11, 2011 /PRNewswire/ — Sequenom, Inc. (NASDAQ:

SQNM), a life sciences company providing innovative genetic
analysis solutions, today announced it has signed a three-year
supply agreement with Illumina, Inc., a leading developer and
manufacturer of life sciences tools for the large-scale analysis of
genetic variation and function.

Under the terms of the agreement, Sequenom and its subsidiaries
will purchase Illumina’s sequencing equipment and consumables for
use in the development of a noninvasive test designed to detect an
overabundance of chromosome 21 in pregnant women, a result
associated with fetal Down syndrome.  

Sequenom and Illumina will work collaboratively toward the
submission for regulatory approval of an in vitro diagnostic
product for the detection of fetal chromosomal abnormalities.

“We are pleased to announce this new partnership with Illumina,
a leader in genetic sequencing systems, as we advance our role in
developing and commercializing prenatal diagnostics,” said Harry F.
Hixson, Jr., Chairman and CEO of Sequenom, Inc. “This agreement is
an important step in bringing our proprietary trisomy test to
market, giving us the scalability, speed to market and supply chain
necessary to address the commercial opportunity of our noninvasive
prenatal test for trisomy 21.”

“We are very pleased to complete this supply agreement with
Sequenom for Illumina’s HiSeq 2000 platform,” said Jay
Flatley, President and CEO of Illumina. “With the most powerful and
cost-effective sequencing technology available, we are fully ready
to meet Sequenom’s needs as it prepares for the commercial launch
of its test.”

About Sequenom

Sequenom, Inc. (NASDAQ:
SQNM) is a life sciences company committed to improving
healthcare through

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 27, 2022
Quick message - No DTW podcast, but plenty else to listen to over this weekend and next week.
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech